Approval · Notice of Compliance 14524 · 2013
CLEVIPREX: Notice of Compliance 14524
Issued July 4, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14524
- Date
- July 4, 2013
- Company
- The Medicines Company
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in drug product formulation, manufacturing site and packaging (sterile product); reduction in drug product shelf life
- Therapeutic class
- Antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLEVIPREX | Not yet assigned | — |
Medicinal ingredients
- CLEVIDIPINE 0.5 MG per ML